Aspirin and NSAID – Risk of COVID-19

Angie Szumlinski Health, Studies

As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease swept the globe, anecdotal reports of a potential exacerbating effect of non-steroidal, anti-inflammatory drugs (NSAIDs), including ibuprofen and aspirin, on COVID-19 emerged, leading to some warnings against the use of NSAIDs. In a study conducted in the United States, United Kingdom, and Sweden using the COVID Symptom Study app about …

Testing – New Onset Febrile Illness

Angie Szumlinski Health, Studies

The effectiveness of coronavirus testing depends not only on the number of tests performed but also on who is getting tested. Testing may be administered for a variety of reasons: to diagnose COVID-19 in symptomatic patients, to detect asymptomatic infection in persons exposed to infection or at high risk of transmitting infection to others (i.e., essential workers), to detect outbreaks …

Vaccines and Long COVID

Angie Szumlinski Health

In a recent article published in MedPage Today, medical experts at the American Academy of Neurology (AAN) annual meeting discussed COVID-19 vaccines and “long hauler” symptoms. “The question of vaccines and different neurological conditions has been studied over the years” said Walter Koroshetz, MD, director o the National institute of Neurological Disorders and Stroke (NINDS). “We don’t have any real …

Brain Damage – COVID-19

Angie Szumlinski Health, Studies

In a news release from EurekaAlert, researchers at Columbia University say that they found no signs of virus inside the patients’ brain cells but saw many brain abnormalities that could explain the confusion and delirium seen in some patients with severe coronavirus and the lingering “brain fog” in those with mild disease. The study, which the authors called the largest …

Loss of Smell and Taste

Angie Szumlinski Health, Studies

A study of about 200 COVID-19 patients last year found that nearly half reported a loss of taste or smell. While most of them regained their senses within four weeks, roughly 10% reported their condition had been unchanged or worse. Doctors are still learning about this COVID-19 related symptom and what possible treatments could be helpful. Some physicians have begun …